Abstract
Patients with intestinal metaplasia (IM) are at increased risk for gastric cancer. Endoscopic surveillance has been shown to anticipate cancer diagnosis in an earlier stage. Cost-effectiveness of endoscopic surveillance in IM patients is unknown. To assess the efficacy and cost-effectiveness of an yearly endoscopic surveillance in patients with IM.
Lingua originale | English |
---|---|
pagine (da-a) | 221-226 |
Numero di pagine | 6 |
Rivista | Helicobacter |
Volume | 15 |
DOI | |
Stato di pubblicazione | Pubblicato - 2010 |
Pubblicato esternamente | Sì |
Keywords
- Aged
- Computer Simulation
- Cost-Benefit Analysis
- Endoscopy, Gastrointestinal
- Humans
- Mass Screening
- Metaplasia
- Middle Aged
- Models, Statistical
- Stomach Diseases